Pulse Biosciences to Present at Stifel 2026 Healthcare Conference
Pulse Biosciences, Inc. announced its scheduled participation and management presentation at the upcoming Stifel 2026 Healthcare Conference.
Stocks · News reference
Pulse Biosciences Schedules Third Quarter 2026 Financial Results Conference Call
Pulse Biosciences has scheduled its third quarter 2026 financial results conference call for November 5, 2026.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K filing — PULSE BIOSCIENCES, INC. (PLSE)
Filed: 2026-10-14 AccNo: 0001437749-26-032601 Size: 171 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Pulse Biosciences Partners With Clayman Thyroid Center At Hospital For Endocrine Surgery In Tampa, Florida
Collaboration adds the nPulse™ Vybrance™ System to patient care at the Hospital for Endocrine Surgery and supports generation of additional clinical dataPulse Biosciences, Inc. (NASDAQ:PLSE), the company leveraging its